Core Insights - Rising Dragon Acquisition Corp. (RDAC.US) is a SPAC focused on finding and completing a merger with a private company by February 14, 2026 [1] Recent Events - The primary event in the SPAC lifecycle is identifying and announcing a merger target, which must occur within 18-24 months of the SPAC's inception. Any rumors or announcements regarding potential merger targets can significantly impact the stock price [2] - After announcing a merger target, the company must undergo shareholder voting and other procedures to finalize the transaction, transforming into a publicly listed company with actual business operations [2] - SPACs face pressure to complete a merger within the designated timeframe, as failure to do so may lead to liquidation and the return of funds (including interest) to shareholders. As the deadline approaches, market attention on the company's progress intensifies [2] Stock Performance - From December 31, 2025, to January 2026, the stock price of RDAC.US experienced significant volatility, with trading volume fluctuating. These movements are typically linked to market expectations regarding the SPAC's merger progress [3] - Recent financial reports indicate that the company has reported zero revenue, reflecting its status as a blank check company [3] Timeline Information - Currently, there is no specific timeline disclosed regarding the key events related to RDAC.US [4]

经济观察网Rising Dragon Acquisition Corp.(RDAC)股价近期大幅下跌，流动性严重不足。 股票近期走势 截至2026年2月11日收盘，RDAC股价报收5.70美元，当日下跌12.31%，创下历史新低。近5个交易日累 计下跌24.00%，年初至今跌幅达41.96%。该股在2月12日交易极为清淡，全天仅成交110股，成交金额 627美元，显示市场流动性严重不足。 市场环境 尽管美股大盘表现稳健(道指上涨0.41%)，但壳公司板块整体缺乏活力。RDAC作为一家2024年3月才成 立的SPAC公司，其股价表现与主营业务明确的公司形成鲜明对比。 以上内容基于公开资料整理，不构成投资建议。 根据2025年第三季度财报，RDAC营业收入为0美元，公司仍处于寻找并购目标的阶段。虽然归母净利 润同比增长4071.19%至45.23万美元，但这主要源于投资活动收益，而非主营业务贡献。公司资产负债 率仅为3.26%，现金及信托账户余额约578万美元，但缺乏持续经营业务收入。 公司项目推进 RDAC在2025年1月与HZJL Cayman Limited签署合并协议，交易对价3.5亿美元，但该交易仍需完 ...

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential investment opportunities before the market opens [1] Premarket Gainers - WhiteFiber, Inc. (WYFI) is up 21% at $17.35 [3] - Rising Dragon Acquisition Corp. (RDAC) is up 21% at $12.63 [3] - Julong Holding Limited (JLHL) is up 13% at $3.45 [3] - Linkhome Holdings Inc. (LHAI) is up 11% at $12.50 [3] - A SPAC III Acquisition Corp. (ASPC) is up 9% at $13.09 [3] - Intuitive Machines, Inc. (LUNR) is up 7% at $11.61 [3] - Ascent Solar Technologies, Inc. (ASTI) is up 7% at $3.31 [3] - Bitmine Immersion Technologies, Inc. (BMNR) is up 6% at $30.39 [3] - Velo3D, Inc. (VELO) is up 5% at $12.10 [3] - Gain Therapeutics, Inc. (GANX) is up 4% at $2.36 [3] Premarket Losers - cbdMD, Inc. (YCBD) is down 17% at $1.60 [4] - Mega Fortune Company Limited (MGRT) is down 16% at $7.33 [4] - Cassava Sciences, Inc. (SAVA) is down 14% at $2.43 [4] - NIKE, Inc. (NKE) is down 10% at $59.01 [4] - InMed Pharmaceuticals Inc. (INM) is down 6% at $1.21 [4] - Datacentrex, Inc. (DTCX) is down 5% at $3.23 [4] - Abundia Global Impact Group Inc (AGIG) is down 5% at $1.50 [4] - PSQ Holdings, Inc. (PSQH) is down 5% at $1.00 [4] - Paranovus Entertainment Technology Ltd. (PAVS) is down 4% at $2.34 [4] - Worksport Ltd. (WKSP) is down 4% at $2.09 [4]

Financial Performance - For the nine months ended September 30, 2025, the company reported a net income of $1,305,166, primarily from interest earned on investments held in the trust account[95] - The company incurred formation and operational costs of $522,744 for the nine months ended September 30, 2025, compared to a net loss of $50,250 for the same period in 2024[95] - The company has no long-term debt or off-balance sheet financing arrangements as of September 30, 2025[104] IPO and Proceeds - The company completed its IPO on October 15, 2024, raising gross proceeds of $50 million from the sale of 5,000,000 units at $10.00 per unit[87] - An additional $7.5 million was generated from the full exercise of the over-allotment option, bringing total proceeds to $57.79 million, which were deposited in a trust account[89] - The company intends to use the net proceeds from the IPO and private placement primarily to complete its initial business combination and for working capital purposes[100] - The company has a deferred underwriting fee of $1,868,750, payable upon the closing of an initial business combination[105] Merger Agreement - The company entered into a merger agreement with HZJL Cayman Limited on January 27, 2025, which is subject to regulatory approvals and shareholder votes[92] Going Concern - Management has expressed concerns about the company's ability to continue as a going concern if an initial business combination is not completed within the prescribed timeframe[103] Cash and Investments - As of September 30, 2025, the company had cash of $5,620 and investments in the trust account totaling $60,158,456[100]

someone dm-ed me this. yes both he and i invested in $RDAC. game is game. https://t.co/Ou8JSpPvZt ...

Core Points - Rising Dragon Acquisition Corp. has postponed its Extraordinary General Meeting from October 20, 2025, to November 20, 2025, to allow shareholders more time to review the definitive proxy statement [1] - The location and record date for the Extraordinary General Meeting remain unchanged, and it will still be held at the offices of Loeb & Loeb LLP in New York [2] - The record date for determining eligible shareholders is September 11, 2025, and shareholders who have already voted do not need to take further action [3] - The deadline for redemption requests related to the proposed business combination has been extended from October 16, 2025, to November 18, 2025 [4] - Shareholders can contact Continental Stock Transfer & Trust Company for questions regarding their position or share delivery [5] - The Company is a blank check company incorporated in the Cayman Islands, aiming to enter into a business combination with one or more entities [7][8]

IPO and Proceeds - The company completed its IPO on October 15, 2024, raising gross proceeds of $50 million from the sale of 5,000,000 units at $10.00 per unit[80]. - An additional $7.5 million was generated from the full exercise of the over-allotment option, bringing total proceeds to $57.79 million, which were deposited in a trust account[80][82]. - The company incurred $1,006,250 in underwriting discounts and $556,288 in other costs related to the IPO[91]. Financial Performance - For the six months ended June 30, 2025, the company reported a net income of $852,848, primarily from interest earned on marketable securities held in the trust account[86]. - As of June 30, 2025, the company had cash of $83,406 and marketable securities in the trust account amounting to $59,536,150[92]. - The company has a working capital of approximately $289,889 as of June 30, 2025[89]. Debt and Financing - The company has no long-term debt or off-balance sheet financing arrangements as of June 30, 2025[96][97]. Business Combination - A merger agreement was entered into on January 27, 2025, with HZJL Cayman Limited for a business combination, subject to regulatory and shareholder approvals[83][84]. - The company intends to use the net proceeds from the IPO and private placement primarily to complete its initial business combination and for working capital[92]. - Management has expressed concerns about the ability to continue as a going concern if the initial business combination is not completed within the prescribed timeframe[95].

IPO and Fundraising - The company completed its IPO on October 15, 2024, raising gross proceeds of $50,000,000 from the sale of 5,000,000 units at an offering price of $10.00 per unit[81]. - An additional $7,500,000 was generated from the full exercise of the over-allotment option, bringing total proceeds to $57,787,500, which were deposited in a trust account[81][83]. - The company incurred $1,006,250 in underwriting discounts and $556,288 in other costs related to the IPO[90]. - The company intends to use the net proceeds from the IPO and private placement primarily to complete its initial business combination and for working capital purposes[91]. Financial Performance - For the three months ended March 31, 2025, the company reported a net income of $453,867, primarily from interest earned on marketable securities held in the trust account[87]. - As of March 31, 2025, the company had cash of $270,259 in its operating bank account and marketable securities in the trust account totaling $58,927,703[91]. - The company has no long-term debt or off-balance sheet financing arrangements as of March 31, 2025[95][96]. Business Combination and Concerns - The company entered into a merger agreement with HZJL Cayman Limited on January 27, 2025, which is subject to regulatory approvals and shareholder votes[84][85]. - The company has a deferred fee obligation of $1,868,750 to underwriters, payable upon closing of the initial business combination[96]. - Management has expressed concerns about the company's ability to continue as a going concern if an initial business combination is not completed within the prescribed timeframe[94].

IPO and Fundraising - The company completed its IPO on October 15, 2024, raising gross proceeds of $50 million from the sale of 5,000,000 units at an offering price of $10.00 per unit[37]. - An additional $7.5 million was generated from the full exercise of the over-allotment option, bringing total proceeds to $57.5 million[37]. - The private placement with Aurora Beacon LLC generated $2,543,750 from the sale of 254,375 private units, which are identical to the IPO units[38]. - A total of $57,787,500 of net proceeds from the IPO and private placement was deposited in a trust account for the benefit of public shareholders[39]. - The trust account initially holds $50,750,000, which can increase to $58,287,500 if the over-allotment option is fully exercised[143]. - The IPO generated gross proceeds of $50,000,000 from the sale of 5,000,000 units, with an additional $7,500,000 from the over-allotment option[168]. - A private placement of 254,375 units was completed simultaneously, generating proceeds of $2,543,750[169]. - Total net proceeds of $57,787,500 from the IPO and private placement were deposited in a trust account[170]. Regulatory and Compliance Risks - The company is subject to significant regulatory risks from the PRC government, which may impact its ability to search for and complete a business combination[49]. - The PRC government has recently implemented new regulations affecting various industries, which could complicate future business combinations and operations[50]. - The company believes it is not required to obtain approvals from PRC authorities for its IPO or to search for a target company, but future regulatory changes could impose new requirements[53]. - The company will not conduct an initial business combination with any target company that operates through variable interest entities (VIEs), limiting the pool of potential acquisition candidates in China[43]. - Recent PRC regulatory actions may create operational risks for any post-business combination company, affecting the ability to conduct business and accept foreign investments[73][76]. - The combined company may face restrictions on paying dividends due to PRC laws, which require profits to be distributable and subject to statutory reserve funds[54]. - The combined company's ability to remit foreign currencies for dividends or loan repayments may be hindered by PRC foreign exchange control regulations[57]. - The PRC government imposes controls on the conversion of RMB into foreign currencies, which may restrict the ability of PRC subsidiaries to remit sufficient foreign currency for dividends[86]. Business Strategy and Target Acquisition - The company intends to pursue target businesses with significant revenue growth, valued between $500 million and $2 billion[92]. - The focus is on high-growth industries such as green and sustainable businesses, new energy, cutting-edge technologies, artificial intelligence applications, business software, and healthcare products[93]. - The strategy includes targeting companies with proven financial performance and growth potential through new products and technological advances[93]. - The management team aims to create shareholder value by identifying target businesses with significant expansion opportunities[101]. - The evaluation of target companies will consider risk-adjusted peak sales potential and the ability to achieve system cost savings[102]. - The management intends to seek companies with low leverage and shareholder-friendly governance, valued at low prices relative to their earnings potential[103]. - The company is not targeting businesses in China but may consider entities with significant ties to China, which could subject the post-business combination business to Chinese laws and regulations[81]. - The company has evaluated approximately three business combination opportunities in Asia and Europe across various sectors before deciding to move ahead with HZJL[91]. Management and Governance - The management team has significant experience in public companies and financial management, which is expected to aid in identifying suitable acquisition targets[66][68]. - The management team is well positioned to capitalize on acquisition opportunities in emerging markets driven by innovative technologies[218]. - The audit committee is comprised solely of independent directors, ensuring compliance with NASDAQ rules[220]. - Chengming Dou qualifies as an "audit committee financial expert" as defined by SEC rules[221]. - The company has established four standing committees: executive, audit, compensation, and nominating[219]. - The nominating committee is responsible for overseeing the selection of board nominees, ensuring a diverse mix of skills and backgrounds[224]. - The company emphasizes the importance of ethical standards and professionalism in selecting director nominees[225]. - The management team has extensive experience in corporate governance and financial accounting, enhancing oversight capabilities[217]. - The board of directors includes members with significant experience in acquisitions, divestitures, and corporate strategy[217]. Financial Performance and Projections - For the year ended December 31, 2024, the company reported a net income of $257,513, primarily from interest earned on marketable securities[175]. - Cash used in operating activities for the year was $326,033, with changes in operating assets and liabilities providing $40,500 of cash[176]. - As of December 31, 2024, the company had cash of $392,679 and marketable securities in the Trust Account of $58,330,546[179]. - The company has not generated any operating revenue to date and will not do so until after completing an initial business combination[174]. - The company has incurred significant costs as a public entity, with cash of $392,679 and working capital equity of $433,179 as of December 31, 2024[146]. - The company has no long-term debt or capital lease obligations, with a deferred fee of $1,868,750 payable upon closing of an initial business combination[184]. - Management believes there will be sufficient working capital to meet anticipated cash needs prior to the initial business combination[181]. Shareholder Rights and Redemption - Public shareholders will have the opportunity to redeem their shares at an anticipated price of $10.05 per share, based on the amount in the trust account[125]. - The company has 15 months from the IPO closing to complete the initial business combination, with the possibility of extending this period up to 21 months[134]. - If the initial business combination is not completed, public shareholders who elected to redeem their shares will not receive their pro rata share of the trust account[133]. - Initial shareholders have agreed to waive their redemption rights for founder shares if the business combination is not consummated within the required timeframe[136]. - The per-share redemption amount upon dissolution is approximately $10.05, which may be subject to claims from creditors[137]. - The company may require public shareholders to tender their shares to exercise redemption rights, which could incur nominal costs[129]. - The company will cease operations and distribute the trust account amount to public shareholders if the business combination is not completed within the allotted time[135]. - There is no guarantee that third parties will waive claims to the trust account, which could affect the company's ability to pursue potential target businesses[138]. Insider Trading and Ethical Standards - The company has adopted a Code of Ethics applicable to all directors, officers, and employees, which is available upon request[229]. - An Insider Trading Policy has been implemented to promote compliance with insider trading laws and regulations[230]. - Potential conflicts of interest exist as officers and directors may not commit full time to the company's affairs, leading to possible allocation conflicts[232]. - Directors and officers owe fiduciary duties under Cayman Islands law, including acting in good faith and exercising independent judgment[236].

Financial Performance - As of September 30, 2024, the company reported a net loss of $50,250 since inception, with a net loss of $11,390 for the three months ended September 30, 2024[78]. - The company had a working capital deficit of approximately $182,336 as of September 30, 2024[79]. - The company has no long-term debt or off-balance sheet financing arrangements as of September 30, 2024[83]. - The company has not engaged in any operations or generated revenue to date, with future revenue expected only after completing an initial business combination[77]. IPO and Fundraising - The company completed its IPO on October 15, 2024, raising gross proceeds of $50 million from the sale of 5,000,000 units at $10.00 per unit[74]. - An additional $7.5 million was generated from the full exercise of the over-allotment option by underwriters[74]. - The private placement with the sponsor generated total proceeds of $2,543,750 from the sale of 254,375 private units[75]. - Total net proceeds of $57,787,500 from the IPO and private placement were deposited in a trust account for public shareholders[76]. - The underwriters are entitled to a deferred fee of 3.25% of the gross proceeds of the IPO, amounting to $1,868,750, payable upon closing of an initial business combination[84]. Management Outlook - Management believes that the company will have sufficient working capital to meet anticipated cash needs prior to the initial business combination[81].